China Pharma Holdings Inc (NYSE MKT LLC:CPHI)

Data as of 4:02pm ET
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Generic

Company Description

China Pharma Holdings, Inc. engages in the development, manufacturing, packaging, marketing and distribution of generic and branded pharmaceutical products for a range of high incidence and high mortality conditions. The company focuses on its therapeutics include CNS, cardiovascular, cerebrovascular, wound recovery, digestive disease, and infectious diseases. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. The company was founded on January 28, 1999 and is headquartered in Haiku, China.

Contact Information

China Pharma Holdings, Inc.
2nd floor, Jiahai Building
Haikou Hainan 570216
Investor Relations:



Individual stakeholders44.69%
Mutual fund holders--
Other institutional--

Top Executives

Zhilin LiChairman, President, Chief Executive Officer & CFO
Yao HuangChief Technology Officer
Jian YangCo-Secretary
Na HuangCo-Secretary

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.